
66PTreatment (tx) characteristics and clinical outcomes in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC) treated with carboplatin (carbo) or cisplatin (cis) in combination with etoposide (etop) in US clinical practice
Sebastian, M, Barlesi, F, Califano, R, Mansfield, A S, Blackhall, F H, Flahavan, E M, Davies, J, Arnold, P, Morris, S, Reck, MVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz071.006
Date:
April, 2019
Fichier:
PDF, 91 KB
2019